GENERAL
Aurobindo Pharma Signs Licensing Agreement With MSD For HIV Drug
Aurobindo Pharma Ltd has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc., Rahway, New Jersey, USA) to manufacture and supply a generic version of the investigational HIV prevention medicine, Alimatravir, in eligible low- and middle-income countries. Aurobindo Pharma is among a select group of global generic […]
CW Bureau
·
Jul 25, 2026
GENERAL
Aurobindo Eyes $494-Mn US Market With Launch Of Tofacitinib Generic
Aurobindo Pharma has strengthened its presence in the lucrative US generics market after receiving final approval from the US Food and Drug Administration (USFDA) for Tofacitinib tablets in 5 mg and 10 mg strengths, opening the door to a market worth nearly $500 million annually. The approval allows the company to manufacture and market a […]
CW Bureau
·
Jun 4, 2026
GENERAL
Sun Pharma Stays Focused On Organic Growth, Disciplined M&A
Sun Pharmaceutical Industries continues to prioritise organic growth, disciplined capital allocation and innovation-led expansion, even as it selectively evaluates acquisition opportunities to strengthen its long-term strategic capabilities, Chairman Dilip Shanghvi said during the company’s latest earnings call. The US remains a core market for Sun Pharma, particularly for its innovative medicines portfolio, while the company […]
Sajan C Kumar
·
Feb 6, 2026
